10-K Decoder · All companies

Lexeo Therapeutics, Inc.

LXEO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$109M−$106M−3.3%
Net income−$100M−$98.3M−1.7%

Questions

What was Lexeo Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Lexeo Therapeutics profitable in FY2025?
No: net income was −$100M and operating income −$109M in FY2025.